Abstract
Heat shock protein peptide complex-96 (HSPPC-96) triggers adaptive and innate antitumor immune responses. The safety and efficacy of HSPPC-96 vaccination was examined in patients with newly diagnosed glioblastoma multiforme (GBM). In this open-label, single-arm, phase I study, adult patients were vaccinated with HSPPC-96 in combination with the standard treatment for newly diagnosed GBM after surgical resection. Primary endpoints were frequency of adverse events and progression-free survival (PFS) at 6 months. Secondary endpoints included overall survival (OS), PFS, and tumor-specific immune response (TSIR). A total of 20 patients with newly diagnosed GBM were enrolled from September 2013 to February 2015. No grade 3 or 4 vaccine-related adverse events were noted. After a median follow-up of 42.3 months, PFS was 89.5% (95% CI, 66.9%-98.7%) at 6 months, median PFS was 11.0 months (95% CI, 8.2-13.8), and median OS was 31.4 months (95% CI, 14.9-47.9). TSIR was significantly increased by 2.3-fold (95% CI, 1.7-3.2) after vaccination. Median OS for patients with high TSIR after vaccination was >40.5 months (95% CI, incalculable) as compared with 14.6 months (95% CI, 7.0-22.2) for patients with low TSIR after vaccination (hazard ratio...Continue Reading
References
Sep 15, 1995·Science·R Suto, P K Srivastava
Oct 6, 1997·Science·Y TamuraP K Srivastava
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H ZhengZ Li
Aug 23, 2002·Journal of Immunological Methods·Song-Dong MengGeorge F Gao
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandro TestoriUNKNOWN C-100-21 Study Group
Mar 26, 2008·British Journal of Cancer·E JonaschN Tannir
Apr 9, 2008·Gastroenterology·Fang-Fang LiuWei-Feng Chen
Mar 10, 2009·The Lancet Oncology·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jan 30, 2010·Journal of Translational Medicine·Omar EtonJeffrey E Lee
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Jul 27, 2011·Cancer Immunology, Immunotherapy : CII·Xiaoli YanSongdong Meng
Aug 9, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Courtney A CraneAndrew T Parsa
Nov 14, 2013·Expert Review of Vaccines·Volker SchirrmacherPeter Schlag
Dec 18, 2013·Neuro-oncology·Orin BlochAndrew T Parsa
Jun 11, 2014·Nature Reviews. Neurology·Wolfgang WickGuido Reifenberger
Sep 6, 2014·Neuro-oncology·David A ReardonGlenn Dranoff
Feb 5, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Debraj GuhaThakurtaCharles G Drake
Jul 19, 2015·Neuro-oncology·Matthew S WaitkusHai Yan
Oct 28, 2015·Oncotarget·Pei YangTao Jiang
Oct 31, 2015·Neuro-oncology·Edjah K NduomAmy B Heimberger
Mar 12, 2016·Nature Reviews. Drug Discovery·Axel Hoos
Oct 16, 2016·Journal of Neuro-oncology·Amanda TivnanJochen H M Prehn
Dec 27, 2016·Biochemical Pharmacology·Davide ManganiPatrick Roth
Jan 5, 2017·Clinical and Translational Medicine·Gabriele D'ErricoBruno Sainz
Apr 24, 2017·Journal of Neuro-oncology·Anna C Filley, Mahua Dey
May 13, 2017·Nature Reviews. Neurology·Michael WellerJohn H Sampson
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonCarl H June
Citations
May 12, 2020·Neuro-oncology·Maryam RahmanDavid A Reardon
Oct 13, 2018·Current Treatment Options in Oncology·Lan B Hoang-Minh, Duane A Mitchell
Nov 23, 2019·International Journal of Molecular Sciences·Rebeca Piatniczka IglesiaMarilene Hohmuth Lopes
Mar 11, 2020·Cancers·Alexey V BaldinAndrey A Zamyatnin
Sep 15, 2020·Chinese Neurosurgical Journal·Chunzhao LiNan Ji
Apr 22, 2020·Oncoimmunology·Yang ZhangQi-Jing Li
Oct 6, 2020·Neuro-oncology Practice·Megan L MontoyaHideho Okada
Nov 16, 2019·Journal of Neuro-oncology·Paula Alcaide-LeonJavier E Villanueva-Meyer
Dec 20, 2018·Cancers·Aleksei A Stepanenko, Vladimir P Chekhonin
Nov 19, 2020·Pharmaceuticals·Karam KhaddourGeorge Ansstas
Aug 14, 2019·Current Opinion in Oncology·Valérie DutoitPierre-Yves Dietrich
Nov 21, 2020·Journal of Neuro-oncology·Christopher FarrellJeffrey J Olson
Mar 7, 2021·Cancers·Hong-My NguyenDipongkor Saha
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shalini Sundramurthi ChelliahIshwar Parhar
Mar 31, 2021·Neurosurgery Clinics of North America·Justin LeeLinda M Liau
May 1, 2021·International Journal of Molecular Sciences·Sanjeev ChawlaHarish Poptani
May 28, 2021·Frontiers in Oncology·Stephen C FredericoMasaki Terabe
Jul 16, 2020·Current Drug Metabolism·Elmira MohtashamiAmir R Afshari
Jun 15, 2021·Frontiers in Neuroscience·Eduard YakubovHans-Herbert Steiner
Jul 25, 2021·Cancers·Chirayu R ChokshiSheila K Singh
Sep 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sumbal RasheedMuhammad Sajid Hamid Akash
Oct 31, 2021·Journal of Hematology & Oncology·Yang XunHua You